Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

The Westin Boston Waterfront

15 ago 2016 7:30 a.m. - 18 ago 2016 5:00 p.m.

425 Summer Street, Boston, MA 02210

Regulatory Affairs: The IND, NDA, and Postmarketing

Session 26: Review of Prescription Drug/Biologics Advertising and Promotional Labeling

Session Chair(s)

Drusilla  Scott, PHD, RAC

Drusilla Scott, PHD, RAC

Vice President, Regulatory Affairs

Sobi, Inc., United States

Carol H. Danielson, DrPH, MS, RAC

Carol H. Danielson, DrPH, MS, RAC

President

Regulatory Advantage, LLC, United States

  • Definitions
  • Statutory Basis for Promotional Regulations
  • Required Elements for Advertisements and Promotional Labeling
  • Reminder Advertisements/Labeling
  • Preapproval Promotional Activities
  • Other Topics
  • FDA Enforcement Actions
  • Launch of Promotional Pieces
  • Postmarketing Submission of Advertising
  • Summary of Principles for Advertising and Promotion

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.